Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study
Join Pharma
|
Login
Editorial
MIRED IN OVERCHARGING CASES
Wednesday, February 12, 2025
Ever since the first Drug Price Control Order was announced by the government way back in 1979 to make essential drugs available at affordable prices, overcharging of drug prices by the pharmaceutical companies has been a major issue.
Past Editorial...
TODAY'S NEWS
17:00 [IST]
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study
16:45 [IST]
Utthunga and VindAir to advance smart solutions for pharma and healthcare industries
16:00 [IST]
NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field
15:00 [IST]
Researchers find single dose of broadly neutralizing antibody protects macaques from H5N1 influenza
14:00 [IST]
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury
13:00 [IST]
Alloy Therapeutics enters multi-year collaboration with Pfizer to develop new antibody discovery platform
more news >>
TOP NEWS
08:00 [IST]
Panel urges Ministry to ensure timely implementation of BPaLM regimen nationwide
08:00 [IST]
AIDCOC urges govt to establish grievance redressal mechanism to address issues related to drug regulations
08:00 [IST]
Investors need to recognize Karnataka as destination where investments grow & innovation thrives: Kiran Mazumdar-Shaw
08:00 [IST]
ICMR invites proposals for joint development of human vaccine against H5N1
08:00 [IST]
Karnataka pharma hopes govt’s Pharma Park at Srinivaspura in Kolar to give fillip to investments
08:00 [IST]
Health ministry issues final notification on extension of revised Schedule M deadline for MSMEs
more news >>
YESTERDAY'S NEWS
18:00 [IST]
Therapy helps peanut-allergic kids tolerate tablespoons of peanut butter: NIH study
17:00 [IST]
WHO, St. Jude launch groundbreaking international delivery of childhood cancer medicines
16:30 [IST]
Clearside Biomedical presents additional data from CLS-AX ODYSSEY phase 2b trial at Angiogenesis, Exudation & Degeneration 2025 meeting
16:00 [IST]
INmune Bio to submit BLA with US FDA seeking approval of CORDStrom to treat recessive dystrophic epidermolysis bullosa in paediatric patients
15:30 [IST]
Nivaan Care pain management clinic chain raises $4.25 million in seed fund from Endiya Partners and W Health Ventures
12:30 [IST]
Glenmark Pharmaceuticals introduces clindamycin phosphate foam, 1%
more news >>
INTERVIEW
Molbio Diagnostics redefines molecular diagnostics with Truenat
Shiva Sriram, President of Molbio Diagnostics
Past Interviews...
What's New?
UPDATED DRUGS (PRICES CONTROL) ORDER, 2013 (Notified by SO 1221 (E) dated 15.05.2013 and as amended up to vide SO2324(E) dated 25-05-2023)
NPPA Corrigendum dated February 7, 2025 in respect of S.O. 5496(E) dated 19.12.2024 related to fixation of separate ceiling price of Synchrobreathe Inhaler Device(129th Authority meeting dated 29.01.2025)
NPPA Notification dated February 7, 2025 revising retail price of 01 new drug application based on review orders(129th Authority meeting dated 29.01.2025)
NPPA notification dated February 7, 2025 revising ceiling price of 02 formulations based on review orders(129th Authority meeting dated 29.01.2025)
NPPA notification dated February 7, 2025 fixing retail prices of 42 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 129th Authority meeting dated 29.01.2025
Opinion Poll
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
Yes
No
Can't Say
View Past Poll
Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
Special Features
Features
Chronicle Pharmabiz Specials
Forthcoming
Past
Forthcoming Events
International
Domestic
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions